NASDAQ · MRVL
Marvell Technology, Inc.
$218.34-$33.31 (-13.24%)
Marvell Technology, Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.81% below the high.
Loading market information…
CNQ · EXM.CN · CAD
Stock price, earnings
Quote as of Feb 26, 2021, 08:45 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow EXMceuticals Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
EXMceuticals Inc. specializes in the development and manufacturing of cannabinoid-derived formulations. The company's primary focus is to match natural, bioactive compounds extracted from the cannabis plant with the specific needs of the nutraceutical, cosmeceutical, therapeutic, and pharmaceutical industries. They produce CBD, a non-intoxicating cannabinoid recognized for its effectiveness against ailments such as acne, anxiety, depression, epilepsy, and neurodegenerative conditions like Parkinson's. Additionally, they produce THC, a psychoactive cannabinoid proven beneficial for pain management, appetite stimulation, anxiety relief, and mitigating chemotherapy side effects. Founded in 2008, the company's head office is located in Quebec, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:36 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$218.34-$33.31 (-13.24%)
Marvell Technology, Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.81% below the high.
CA$5.10-CA$3.40 (-40.0%)
IM Cannabis Corp.’s quoted price sits in the lower half of its reported 52-week range, 47.42% below the high.
CA$0.30+CA$0.04 (+13.46%)
Antibe Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.02% below the high.
CA$0.11CA$0.00 (0.0%)
LexaGene Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 65.0% below the high.
CA$0.23CA$0.00 (0.0%)
Chalice Brands Ltd.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.10-CA$0.01 (-4.76%)
RIV Capital Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.40CA$0.00 (0.0%)
Orion Nutraceuticals Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.02-$0.00 (-20.0%)
Numinus Wellness Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.91% below the high.
